The programme, “Connecting UAE-Israel”, will begin this month with a series of briefing webinars which will match both up-and-coming entrepreneurial talent and established companies in Israel with savvy business investors and experts within the emirates, this in hopes to connect the UAE and Israel and help unite both countries for the sake of progress and prosperity

“We are highly pleased to introduce the next phase in Israel and the UAE’s historic peace accords” says Kamir Strategy Founder and Chairman, Eli Kamir. “Kamir and Cosmopole will be combining their industry-leading management consulting services, cross-cultural and multinational expertise and world-class strategy-led services, in order to build and create new business opportunities and ventures for the Biomed sector, both in Israel and in the UAE.”

In close collaboration with Cosmopole, a consultancy specialising in public relations and digital marketing, the two agencies hope to connect both counties and encourage business partnerships and bilateral relationships following the ground-breaking Abraham Accords.

The first in the virtual online series, “Connecting UAE-Israel: Investment Opportunities in Healthcare”, will take place on October 26 and will focus on innovation in medicine; primarily biotech, medtech and general healthcare technology.

Aviad Tamir, the Head of Life Sciences & Healthcare at Invest in Israel, will give the opening address, with his keynote focusing on an ‘Overview of the Healthcare Ecosystem at Invest in Israel’. Attendees to the webinar will hear presentations from the CEOs, CFOs, founders, and medical experts behind several Israel healthcare companies which are garnering rising prominence globally.

Companies include Ayana Pharma, a pharmaceutical company focused on the development of Liposomal Therapeutics – currently waiting for FDA approval – to treat cancer, and MediWound; a biotechnology niche specialty company, focused on developing, manufacturing and globally commercialising innovative products to address unmet needs in the field of severe burns and chronic wound treatment. 

Awaiting the upcoming webinar and promises this new initiative brings, Sharon Malka, MediWound’s CEO said that they “are excited with the new opportunities created by the Peace treaty with the UAE. Israel is internationally known for its groundbreaking achievements in science and medicine, and this collaboration with the UAE bares great potential for future discoveries and for the development of a thriving Biomed industry in the UAE. We look forward to begin this journey”.

Allen Baharaff (Photo by Arkadi Raskin)

Furthermore, presentations will be heard from Galmed, a clinical-stage biopharmaceutical company focused on disease-modifying treatment for fatty liver disorders, Inretio, a company developing treatment for ischemic stroke treatment, and aVISI, a pharma company developing a drug delivery for leading causes of visual impairment and blindness.

Galmed pharmaceutical’s President and CEO, Allen Baharaff, stated: “The signs and voices of peace between our nations are fast becoming a reality that we are so happy to be part of. Galmed is currently leading the largest global registrational study for NASH which is a major health concern in the Middle East . I hope the UAE will soon become part of the 200 medical centers in 18 countries across 5 continents participating in this study. We look forward to joining forces leveraging on Israeli innovation to the benefit of millions of patients in need.”

Sharon Malka (Photo by Yosi Zelliger)

“The UAE and Israel are two of the most developed and innovative countries in the Middle East, if not the entire world,” said Claire Micheletti, Managing Director of Cosmopole. “Both are known for their consistent pursuit of social, economic and financial stability. On September 15th, 2020, both countries decided to take their relationships one step forward, towards a better future. The Abraham Accords is the cornerstone of many new opportunities to come, and ‘Connecting UAE-Israel’ is a liaison hub designed to foster connections and introductions between a broad diversity of companies from the UAE and Israel. 

The webinar “Connecting UAE-Israel: Investment Opportunities in Healthcare” will take place on October 26 at 5pm Israel time.

About The Publishers
Releases published on the JNS Wire are communicated and paid for by third parties. Jewish News Syndicate, and any of its distribution partners, take zero responsibility for the accuracy of any content published in any press release. All the statements, opinions, figures in text or multimedia including photos or videos included in each release are presented solely by the sponsoring organization, and in no way reflect the views or recommendation of Jewish News Syndicate or any of its partners. If you believe any of the content in a release published on JNS Wire is offensive or abusive, please report a release.